nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Crystal-storing histiocytosis: An unusual relapsing inflammatory CNS disorder
|
Costanzi, Chiara |
|
2012 |
1 |
2 |
p. 95-99 5 p. |
artikel |
2 |
Editors' welcome
|
Banwell, Brenda |
|
2012 |
1 |
2 |
p. 55- 1 p. |
artikel |
3 |
Emerging disease modifying treatments—A therapeutics update from ECTRIMS/ACTRIMS, Amsterdam, 2011
|
Giovannoni, Gavin |
|
2012 |
1 |
2 |
p. 56-58 3 p. |
artikel |
4 |
Epstein–Barr virus in the multiple sclerosis brain – An evasive culprit
|
Pender, Michael P. |
|
2012 |
1 |
2 |
p. 61-63 3 p. |
artikel |
5 |
Moyamoya: Another multiple sclerosis mimic
|
Zaheer, Fariha |
|
2012 |
1 |
2 |
p. 100-103 4 p. |
artikel |
6 |
Multiple sclerosis and risk behavior
|
Hawkes, Christopher H. |
|
2012 |
1 |
2 |
p. 59-60 2 p. |
artikel |
7 |
Patient-rated ease of use and functional reliability of an electronic autoinjector for self-injection of subcutaneous interferon beta-1a for relapsing multiple sclerosis
|
Singer, B. |
|
2012 |
1 |
2 |
p. 87-94 8 p. |
artikel |
8 |
The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis
|
Baker, David |
|
2012 |
1 |
2 |
p. 64-75 12 p. |
artikel |
9 |
The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristics
|
Lindsey, J.W. |
|
2012 |
1 |
2 |
p. 81-86 6 p. |
artikel |
10 |
Urine: An under-studied source of biomarkers in multiple sclerosis?
|
Dobson, Ruth |
|
2012 |
1 |
2 |
p. 76-80 5 p. |
artikel |